-

SIVB Shareholder News: Johnson Fistel Encourages SVB Financial Shareholders with Losses to Contact the Firm Regarding Class Action Investigation

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Johnson Fistel, LLP is investigating whether SVB Financial Group (“SVB” or “the Company”) (NASDAQ: SIVB) investors' losses may be recovered under the federal securities laws.

What if I purchased SVB common stock? If you purchased SVB common stock and suffered significant losses on your investment, join our investigation now:

Click or paste the following web address into your browser to submit your losses:

https://www.cognitoforms.com/JohnsonFistel/SVBFinancialGroup

Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471

There is no cost or obligation to you.

What is Johnson Fistel investigating? On March 8, 2023, SVB announced it is seeking to raise more than $2 billion, made up of $500 million from private equity firm General Atlantic and $1.75 billion via a public equity offering. SVB also disclosed it sold nearly $21 billion of securities it held and that it will take a $1.8 billion loss on the transaction.

Following this news, on March 9, 2023, the stock was down over 30% in pre-market trading.

What if I have relevant nonpublic information? Individuals with nonpublic information regarding the company should consider whether to assist our investigation or take advantage of the SEC Whistleblower program. Under the SEC program, whistleblowers who provide original information may, under certain circumstances, receive rewards totaling up to thirty percent of any successful recovery made by the SEC. For more information, contact Jim Baker at (619) 814-4471 or jimb@johnsonfistel.com.

Contacts

Johnson Fistel, LLP
Jim Baker, Lead Securities Analyst
Telephone: (619) 814-4471
Email: jimb@johnsonfistel.com

Johnson Fistel, LLP

NASDAQ:SIVB

Release Versions

Contacts

Johnson Fistel, LLP
Jim Baker, Lead Securities Analyst
Telephone: (619) 814-4471
Email: jimb@johnsonfistel.com

More News From Johnson Fistel, LLP

Capricor Therapeutics Investors Who Suffered Losses Are Encouraged to Contact Johnson Fistel

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating whether Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) or certain of its officers and directors violated federal securities laws by misrepresenting or failing to timely disclose material information to investors. What if I purchased Capricor securities? If you purchased Capricor securities and suffered losses on your investment, you may join our investigation now: Click Here to Join the Investigation. Or...

HYLN Investor Notice: Johnson Fistel Investigates Hyliion Holdings Corp.

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating Hyliion Holdings Corp. (NYSE American: HYLN) on behalf of investors who suffered losses and whether those losses may be recoverable under federal securities laws.What Should Hyliion Investors Do?If you purchased Hyliion securities and suffered losses on your investment, you are encouraged to contact Johnson Fistel to learn more about the investigation.To join the investigation click here.For more information, contact Jim Baker at...

Simulations Plus (SLP) Investigation: Investors Who Suffered Losses Encouraged to Contact Johnson Fistel

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating potential securities law violations on behalf of investors of Simulations Plus, Inc. (NASDAQ: SLP). The investigation concerns whether Simulations Plus or certain of its officers and directors made false or misleading statements, or failed to disclose material information, concerning the Company’s financial outlook, reporting practices, internal controls, and related accounting matters. Simulations Plus Investors: Contact Johnson...
Back to Newsroom